34 results on '"Messina, John C."'
Search Results
2. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis
3. Development of computational fluid dynamics methodology for characterization of exhalation delivery system performance in a nasal airway with Draf-III surgery
4. EDS‐FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps
5. Development of Computational Fluid Dynamics (Cfd) Methodology for Characterization of Exhalation Delivery System (Eds) Performance
6. The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview
7. Breath Powered Nasal Delivery: A New Route to Rapid Headache Relief
8. EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis
9. Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts
10. Accessing the Brain: The Nose may Know the Way
11. Supplemental material for NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps
12. EDS-FLU performs differently than other nasal corticosteroids
13. Evidence for Twice-Daily Nasal Steroids Versus Once Daily for Treatment of Chronic Rhinosinusitis with Nasal Polyps
14. Lifetime Work Productivity Gains Among Patients with Chronic Rhinosinusitis with Nasal polyps (CRSwNP) Treated with EDS-FLU
15. Evidence is Limited for the Efficacy and Safety of Corticosteroid Irrigation in Chronic Rhinosinusitis (CRS)
16. A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis
17. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps
18. ANTIEMETIC THERAPY FOR ALZHEIMER'S PATIENTS RECEIVING THE CHOLINESTERASE INHIBITOR SDZ ENA 713
19. Deposition of drugs in the nose and sinuses with an exhalation delivery system vs conventional nasal spray or high-volume irrigation in Draf II/III post-surgical anatomy.
20. EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.
21. Economic Impact Associated with a Reduction in Surgical Eligibility among Adult Patients with Chronic Rhinosinusitis - A Population Cost Offset Model
22. EDS-FLU Improves Quality of Life and Health Status: Pooled Analysis of Phase 3 Trials Navigate I and II
23. Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Health-Related Quality of Life (HRQoL) in Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from NAVIGATE II
24. Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Outcomes in Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) in Patients With or Without Recent Intranasal Steroid Use
25. Disease Burden of Chronic Rhinosinusitis (CRS) is as Severe as Other Serious Chronic Diseases
26. Exhalation Delivery Systems (EDS) Greatly Increase Topical Delivery to Target Sites for Chronic Rhinosinusitis (CRS) Compared to Nasal Sprays or Pressurized MDIs (pMDI)
27. A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis
28. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
29. Exhalation Delivery System (EDS) Intranasal Steroid vs Conventional Inhaled Nasal Steroids (INS): Patient Preference, Comfort and Ease of Use
30. Spectrum of ADL impairment and response to rivastigmine varies by severity of alzheimer's disease
31. Cost savings from decreased utilization of antipsychotic drugs associated with rivastigmine use in long term care facilities
32. Safety of rivastigmine in Alzheimer's disease: Pooled results from phase III studies
33. Presence of vascular risk factors in ad patients predicts greater response to cholinesterase inhibition
34. Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.